{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:17:04Z","timestamp":1790201824908,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.biopha.2018.01.158","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T05:42:06Z","timestamp":1518068526000},"page":"184-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7"],"prefix":"10.1016","volume":"100","author":[{"given":"Xiaoqian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.01.158_bib0005","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/dsu.12346","article-title":"Intralesional treatment for keloids and hypertrophic scars: a review","volume":"39","author":"Ledon","year":"2013","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.biopha.2018.01.158_bib0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.biopha.2018.01.158_bib0015","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1371\/journal.pmed.0040234","article-title":"Hypertrophic scar formation following burns and trauma: new approaches to treatment","volume":"4","author":"Aarabi","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.biopha.2018.01.158_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12079-013-0195-5","article-title":"The molecular mechanism of hypertrophic scar","volume":"7","author":"Zhu","year":"2013","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2018.01.158_bib0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/rme.14.54","article-title":"Wound healing: an update","volume":"9","author":"Zielins","year":"2014","journal-title":"Regen. Med."},{"key":"10.1016\/j.biopha.2018.01.158_bib0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.01.158_bib0035","first-page":"S54","article-title":"TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring","volume":"15","author":"Cutroneo","year":"2007","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.biopha.2018.01.158_bib0040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbrc.2003.09.130","article-title":"Interaction of Smads with collagen types I, III, and V","volume":"310","author":"Ellis","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.01.158_bib0045","first-page":"s10","article-title":"Mechanisms of pathological scarring: role of myofibroblasts and current developments","volume":"19","author":"Sarrazy","year":"2011","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.biopha.2018.01.158_bib0050","first-page":"2225","article-title":"Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent","volume":"40","author":"Cordeiro","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2018.01.158_bib0055","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archoto.2010.107","article-title":"Inhibition of Smad3 expression in radiation-induced fibrosis using a novel method for topical transcutaneous gene therapy","volume":"136","author":"Lee","year":"2010","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.biopha.2018.01.158_bib0060","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.bjps.2006.05.007","article-title":"Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts","volume":"60","author":"Wang","year":"2007","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"10.1016\/j.biopha.2018.01.158_bib0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.cell.2005.07.031","article-title":"Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation","volume":"122","author":"Bagga","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.01.158_bib0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.01.158_bib0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.01.158_bib0080","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI84424","article-title":"Targeting noncoding RNAs in disease","volume":"127","author":"Adams","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.01.158_bib0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.24071","article-title":"What goes up must come down: the emerging role of microRNA in fibrosis","volume":"53","author":"Chau","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.01.158_bib0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrcardio.2014.125","article-title":"Noncoding RNAs and myocardial fibrosis","volume":"11","author":"Thum","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2018.01.158_bib0095","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/jcb.25873","article-title":"Non-coding RNAs: the new insight on hypertrophic scar","volume":"118","author":"Chen","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.01.158_bib0100","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00018-015-1853-y","article-title":"An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs","volume":"72","author":"Wang","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2018.01.158_bib0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1139\/cjpp-2016-0248","article-title":"miR-29b promotes skin wound healing and reduces excessive scar formation by inhibition of the TGF-beta1\/Smad\/CTGF signaling pathway","volume":"95","author":"Guo","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.158_bib0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40659-017-0127-6","article-title":"MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1","volume":"50","author":"Bi","year":"2017","journal-title":"Biol. Res."},{"key":"10.1016\/j.biopha.2018.01.158_bib0115","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins","volume":"460","author":"Finkel","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.01.158_bib0120","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrc3985","article-title":"The multifaceted functions of sirtuins in cancer","volume":"15","author":"Chalkiadaki","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.01.158_bib0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cellsig.2014.11.026","article-title":"Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh Sirtuin!","volume":"27","author":"Kiran","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2018.01.158_bib0130","first-page":"531","article-title":"SIRT7 an emerging sirtuin: deciphering newer roles","volume":"64","author":"Kim","year":"2013","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.158_bib0135","doi-asserted-by":"crossref","first-page":"L945","DOI":"10.1152\/ajplung.00473.2016","article-title":"Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts","volume":"312","author":"Wyman","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2018.01.158_bib0140","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.114.014821","article-title":"Sirt7 contributes to myocardial tissue repair by maintaining transforming growth factor-beta signaling pathway","volume":"132","author":"Araki","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2018.01.158_bib0145","doi-asserted-by":"crossref","first-page":"22003","DOI":"10.18632\/oncotarget.15781","article-title":"MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.01.158_bib0150","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.18632\/oncotarget.14833","article-title":"E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C","volume":"8","author":"Sang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.01.158_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-016-2699-9","article-title":"MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF\/CCN2 via the Akt\/mTOR pathway","volume":"416","author":"Mu","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.01.158_bib0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.yexcr.2016.05.013","article-title":"Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts","volume":"345","author":"Li","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2018.01.158_bib0165","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2011.04.002","article-title":"MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703","volume":"307","author":"Hou","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2018.01.158_bib0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/OTT.S60289","article-title":"MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP","volume":"7","author":"Pang","year":"2014","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.biopha.2018.01.158_bib0175","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3892\/or.2015.4160","article-title":"miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression","volume":"34","author":"Deng","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2018.01.158_bib0180","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317694566","article-title":"Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H","volume":"39","author":"Bai","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.biopha.2018.01.158_bib0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-017-3049-2","article-title":"C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer","volume":"434","author":"Yang","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.01.158_bib0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-016-0480-2","article-title":"Oleuropein enhances radiation sensitivity of nasopharyngeal carcinoma by downregulating PDRG1 through HIF1alpha-repressed microRNA-519d","volume":"36","author":"Xu","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2018.01.158_bib0195","doi-asserted-by":"crossref","first-page":"9787","DOI":"10.1038\/srep09787","article-title":"Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.01.158_bib0200","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.3892\/or.2016.5063","article-title":"MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells","volume":"36","author":"Shi","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2018.01.158_bib0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.yexcr.2014.11.001","article-title":"Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response","volume":"331","author":"Kiran","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2018.01.158_bib0210","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.7150\/thno.18804","article-title":"Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer","volume":"7","author":"Tang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2018.01.158_bib0215","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.107.164558","article-title":"Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice","volume":"102","author":"Vakhrusheva","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.01.158_bib0220","doi-asserted-by":"crossref","first-page":"e0178530","DOI":"10.1371\/journal.pone.0178530","article-title":"Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.01.158_bib0225","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/hep.26101","article-title":"Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.01.158_bib0230","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1016\/j.febslet.2013.10.023","article-title":"Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1","volume":"587","author":"Han","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2018.01.158_bib0235","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.celrep.2015.08.006","article-title":"MiR-93 controls adiposity via inhibition of Sirt7 and Tbx3","volume":"12","author":"Cioffi","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2018.01.158_bib0240","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/1873-3468.12138","article-title":"miR-152 induces human dental pulp stem cell senescence by inhibiting SIRT7 expression","volume":"590","author":"Gu","year":"2016","journal-title":"FEBS Lett."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217360328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217360328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T18:08:18Z","timestamp":1761242898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217360328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":48,"alternative-id":["S0753332217360328"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.158","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-519d inhibits proliferation and induces apoptosis of human hypertrophic scar fibroblasts through targeting Sirtuin 7","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}